How to Get CagriSema Online in Latvia

If you're searching for CagriSema online in Latvia, it's important to understand its current status. CagriSema is a promising new medication in development, but it is currently not approved for weight-loss prescription anywhere in the European Union, including Latvia. Consequently, Hi-Doctor does not offer CagriSema at this time. Here's what CagriSema actually is, why it's not yet available, and what proven, approved weight-loss treatments you CAN get today from an EU-licensed doctor.

What is CagriSema, and why isn't it a normal option yet?

CagriSema is an investigational medication combining two compounds: semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analog). This combination aims to provide a more comprehensive approach to weight management by targeting multiple pathways involved in appetite regulation and metabolism. While clinical trials have shown encouraging results, particularly in Phase 3 studies, it has not yet received marketing authorization from the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA). This means it is not legally available for prescription outside of clinical trial settings. Any sources claiming to sell CagriSema online are unregulated and pose significant safety risks, including the potential for counterfeit products.

Proven weight-loss medications available online today

While CagriSema is not yet an option, several effective and EMA-approved weight-loss medications are available through a doctor's prescription. These treatments have undergone rigorous testing and are proven to be safe and effective when prescribed under medical supervision.

• Ozempic (semaglutide): Primarily for type 2 diabetes, it also aids weight loss and is prescribed off-label for suitable patients.
• Wegovy (semaglutide): A higher-dose formulation of semaglutide specifically approved for chronic weight management in adults with obesity or overweight and comorbidities.
• Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist for type 2 diabetes, also demonstrating significant weight loss, prescribed off-label for eligible patients.
• Saxenda (liraglutide): A GLP-1 receptor agonist approved for chronic weight management, administered daily.

How to get a weight-loss prescription online in Latvia

Hi-Doctor makes it straightforward to access approved weight-loss treatments through EU-licensed medical professionals. Here’s how you can get a prescription online in Latvia:

1. Complete an online questionnaire: Spend 2-3 minutes providing your medical history and current health status.
2. Doctor review: An EU-licensed doctor will individually review your case to determine if treatment is appropriate for you. There is a €25 consultation fee, which is automatically refunded if the doctor determines treatment is not suitable.
3. Receive your prescription: If approved, a REMPE electronic prescription (valid EU-wide) will be issued within 24 hours. You'll receive a downloadable PDF in your private account and by email.
4. Pick up at any EU pharmacy: Your prescription is valid at any pharmacy in any EU country under the cross-border prescription directive 2011/24/EU.

Why choose Hi-Doctor over unregulated peptide sellers

Choosing Hi-Doctor ensures your safety and access to legitimate, high-quality medical care. We offer:

• EU-licensed doctors: All consultations and prescriptions are handled by qualified professionals.
• Real medications: You receive genuine, EMA-approved medications from registered pharmacies.
• Medical oversight: Your health is monitored, and treatment plans are tailored to your specific needs.
• Secure and traceable: All interactions are within a private, RGPD-compliant account.
• Trusted service: With over 50,000 patients served and a 4.8 Trustpilot rating, you can rely on our expertise.

Unregulated peptide sellers offer 'research chemicals' without medical oversight, risking your health with unknown purity, dosage, and potential side effects.